The Effect of Ocrelizumab on Anti-JC Virus Antibody Index, B Cells and Immunoglobulins: a Longitudinal Study

被引：0
|
作者：
Virupakshaiah, A. [1 ]
Gill, A. [2 ]
Schoeps, V. A. [1 ]
Wilson, E. [3 ]
Wilson, J. [3 ]
Jacobs, D. [4 ]
Do, D. [3 ]
Berger, J. R. [4 ]
机构：
[1] UCSF, Neurol, San Francisco, CA USA
[2] Johns Hopkins Med, Neurol, Baltimore, MD USA
[3] Penn Med, Neurol, Philadelphia, PA USA
[4] Univ Penn, Neurol, Philadelphia, PA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P173
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [1] Longitudinal stability of anti-JC virus antibody index over two years in patients treated with natalizumab in the ASCEND study
    Mason, L.
    Berger, T.
    Kapoor, R.
    Hartung, H. -P.
    Chang, I.
    Ren, Z.
    Campbell, N.
    Ho, P. -R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 501 - 502
  • [2] Anti-JC Virus Antibody Prevalence in Canadian MS Patients
    Bhan, Virender
    Lapierre, Yves
    Freedman, Mark S.
    Duquette, Pierre
    Selchen, Daniel
    Migounov, Vladimir
    Walt, Len
    Zhang, Annie
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2014, 41 (06) : 748 - 752
  • [3] Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients
    Baber, Ursela
    Bouley, Andrew
    Egnor, Emily
    Sloane, Jacob A.
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2342 - 2345
  • [4] Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients
    Ursela Baber
    Andrew Bouley
    Emily Egnor
    Jacob A. Sloane
    Journal of Neurology, 2018, 265 : 2342 - 2345
  • [5] Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
    Olsson, Tomas
    Achiron, Anat
    Alfredsson, Lars
    Berger, Thomas
    Brassat, David
    Chan, Andrew
    Comi, Giancarlo
    Eraksoy, Mefkure
    Hegen, Harald
    Hillert, Jan
    Jensen, Poul Erik Hyldgaard
    Moiola, Lucia
    Myhr, Kjell-Morten
    Oturai, Annette
    Schippling, Sven
    Siva, Aksel
    Sorensen, Per Soelberg
    Trampe, Anne-Kathrin
    Weber, Thomas
    Potts, James
    Plavina, Tatiana
    Paes, Dominic
    Subramanyam, Meena
    Wiendl, Heinz
    Dib, Hussein
    Uren, Deniz
    Hemmer, Bernhard
    Buck, Dorothea
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1533 - 1538
  • [6] Longitudinal stability of anti-JC virus (JCV) antibody index over 2 years in multiple sclerosis (MS) patients treated with natalizumab in the ASCEND study
    Mason, Louise
    Berger, Thomas
    Kapoor, Raju
    Hartung, Hans-Peter
    Chang, Ih
    Ren, Zheng
    Campbell, Nolan
    Ho, Pei-Ran
    NEUROLOGY, 2019, 92 (15)
  • [7] An Evaluation of the Longitudinal Stability of Anti-JC Virus (JCV) Antibody Levels in Patients with Multiple Sclerosis (MS)
    Donovan, Emily
    LaGanke, Christopher
    NEUROLOGY, 2016, 86
  • [8] Anti-JC virus antibody prevalence in the JCV Epidemiology in MS trial
    Bozic, C.
    Subramanyam, M.
    Paes, D.
    Richman, S.
    Plavina, T.
    Zhang, A.
    Ticho, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 371 - 372
  • [9] Influenza-virus-vaccineIncrease in anti-JC virus antibody levels: case report
    Reactions Weekly, 2016, 1614 (1) : 100 - 100
  • [10] The effect of plasma exchange on serum anti-JC virus antibodies
    Subramanyam, Meena
    Plavina, Tatiana
    Khatri, Bhupendra O.
    Fox, Robert J.
    Goelz, Susan E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (07) : 912 - 919
12345